Clinical trial
Clopidogrel or Ticagrelor in Acute Coronary Syndrome Patients Treated With Newer-Generation Drug-Eluting Stents: CHANGE DAPT
NCT03197298 is registered in ClinicalTrials.gov with Thorax Centrum Twente as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clopidogrel or Ticagrelor in Acute Coronary Syndrome Patients Treated With Newer-Generation Drug-Eluting Stents: CHANGE DAPT
- Lead sponsor
- Thorax Centrum Twente
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 21, 2012
- Completion date
- July 25, 2016
- Enrollment
- 2,062 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, drug-eluting stents, percutaneous coronary intervention